We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

50 hedge funds and large institutions have $469M invested in Vera Therapeutics in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

188% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 8

35% more funds holding

Funds holding: 37 → 50 (+13)

25% more capital invested

Capital invested by funds: $375M → $469M (+$94M)

6.64% more ownership

Funds ownership: 67.02% → 73.66% (+6.6%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
50
Holders Change
+13
Holders Change %
+35.14%
% of All Funds
0.79%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
15
Increased
23
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$42.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.7M
3
VC
Vivo Capital
California
+$14.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$7.67M
5
LGM
Logos Global Management
California
+$7.21M

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$8.87M
2
OCA
Octagon Capital Advisors
New York
-$2.06M
3
PHP
Parkman Healthcare Partners
Connecticut
-$576K
4
CMU
Carnegie Mellon University
Pennsylvania
-$346K
5
Jane Street
Jane Street
New York
-$221K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$419K – – –
GTCM
27
Gyon Technologies Capital Management
New Jersey
$398K -$163K -7,592 -31%
CMU
28
Carnegie Mellon University
Pennsylvania
$377K -$346K -16,060 -50%
Bank of America
29
Bank of America
North Carolina
$367K +$79.5K +3,697 +31%
Ensign Peak Advisors
30
Ensign Peak Advisors
Utah
$312K +$286K +13,277 New
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$258K +$95.4K +4,434 +68%
Citigroup
32
Citigroup
New York
$256K +$177K +8,238 +310%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$244K +$223K +10,385 New
CT
34
Cambridge Trust
Massachusetts
$232K – – –
MIM
35
MetLife Investment Management
New Jersey
$209K +$191K +8,881 New
Deutsche Bank
36
Deutsche Bank
Germany
$191K +$45K +2,091 +35%
AIG
37
American International Group
New York
$160K +$33K +1,535 +29%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$137K +$9.34K +434 +8%
Wells Fargo
39
Wells Fargo
California
$69K -$59K -2,742 -48%
Barclays
40
Barclays
United Kingdom
$53K +$47.8K +2,222 New
UBS Group
41
UBS Group
Switzerland
$47K +$43.2K +2,009 New
SO
42
STRS Ohio
Ohio
$37K – – –
AB
43
Amalgamated Bank
New York
$34K +$30.9K +1,438 New
AF
44
Amalgamated Financial
New York
$34K +$30.9K +1,438 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$32K -$29.2K -1,355 -50%
Legal & General Group
46
Legal & General Group
United Kingdom
$31K +$8.05K +374 +40%
AIP
47
Ameritas Investment Partners
Nebraska
$25K +$11.2K +519 +96%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$24.5K +$22.4K +1,041 New
US Bancorp
49
US Bancorp
Minnesota
$23K +$21.5K +1,000 New
TRCT
50
Tower Research Capital (TRC)
New York
$5K -$6.69K -311 -58%
1
2
3

VERA Hedge Fund Activity: Q1 2022 in Review

50 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q1 2022, worth a combined $469M — up 25% from $375M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VERA positions and 2 closed out — a net gain of 13 holders — while 23 added to existing stakes and 8 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $42.3M. The largest seller was Alphabet Inc, cutting an estimated $8.87M.

  • 50 institutional investors held Vera Therapeutics (VERA) as of Q1 2022, up from 37 in Q4 2021.
  • Funds reported $469M of Vera Therapeutics stock for Q1 2022, up 25% quarter-over-quarter.
  • 15 funds opened new Vera Therapeutics positions in Q1 2022 and 2 closed out, a net change of +13 holders.
  • The largest Vera Therapeutics buyer in Q1 2022 was RA Capital Management, an estimated $42.3M added.
  • The largest Vera Therapeutics seller in Q1 2022 was Alphabet Inc, an estimated $8.87M sold.

Based on aggregated 13F filings for Q1 2022.